Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models
Yang, Weimin1; Qiang, Dongjin1; Zhang, Min1; Ma, Limei1; Zhang, Yonghui1; Qing, Chen1; Xu, Yunlong2; Zhen, Chunlan1; Liu, Jikai2; Chen, Yan-Hua3
2011-06-01
发表期刊INTERNATIONAL IMMUNOPHARMACOLOGY
ISSN1567-5769
卷号11期号:6页码:683-692
摘要Isoforskolin was isolated from Coleus forskohlii native to Yunnan in China. We hypothesize that isuforskolin pretreatment attenuates acute lung injury induced by lipopolysaccharide (endotoxin). Three acute lung injury models were used: situ perfused rat lung, rat and mouse models of endotoxic shock. Additionally, lipopolysaccharide stimulated proinflammatory cytokine production was evaluated in human mononuclear leukocyte. In situ perfused rat lungs, pre-perfusion with isoforskolin (100, and 200 mu M) and dexarrethasone (65 mu M, positive control) inhibited lipopolysaccharide (10 mg/L) induced increases in lung neutrophil adhesion rate, myeloperoxidase activity, lung weight Wet/Dry ratio, permeability-surface area product value, and tumor necrosis factor (TNF)-alpha levels. In rats, pretreatments with isoforskolin (5, 10, and 20 mg/kg, i.p.) and dexamethasone (5 mg/kg, i.p.) markedly reduced lipopolysaccharide (6 mg/kg i.v.) induced increases of karyocyte, neutrophil counts and protein content in bronchoalveolar lavage fluid, and plasma myeloperoxidase activity. Lung histopathology showed that morphologic changes induced by lipopolysaccharide were less pronounced in the isoforskolin and dexamethasone pretreated rats. In mice, 5 mg/kg isoforskolin and dexamethasone caused 100% and 80% survival, respectively, after administration of lipopolysaccharide (62.5 mg/kg, iv., 40% survival if untreated). In human mononuclear leukocyte, isoforskolin (50, 100, and 200 mu M) and dexamethasone (10 mu M) pre-incubation lowered lipopolysaccharide (2 mu g/mL) induced secretion of the cytokine TNF-alpha, and interleukins (IL)-1 beta, IL-6, and IL-8. In conclusion, pretreatment with isoforskolin attenuates lipopolysaccharide-induced acute lung injury in several models, and it is involved in down-regulation of inflammatory responses and proinflammatory cytokines TNF-alpha, IL-1 beta, IL-6, and IL-8. (C) 2011 Elsevier B.V. All rights reserved.
关键词Acute Lung Injury Isoforskolin Lipopolysaccharide Inflammation Cytokine
资助信息National Natural Science Foundation of China[30560174]; Yunnan Provincial Natural Science Foundation[2004C0048M]
学科领域Immunology ; Pharmacology & Pharmacy
DOI10.1016/j.intimp.2011.01.011
收录类别SCI
语种英语
WOS研究方向Immunology ; Pharmacology & Pharmacy
WOS类目Immunology ; Pharmacology & Pharmacy
WOS记录号WOS:000291505900007
引用统计
被引频次:16[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/5353
专题植物化学与西部植物资源持续利用国家重点实验室
作者单位1.Kunming Med Coll, Yunnan Key Lab Pharmacol Nat Prod, Kunming 650031, Peoples R China
2.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming 650204, Peoples R China
3.E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA
推荐引用方式
GB/T 7714
Yang, Weimin,Qiang, Dongjin,Zhang, Min,et al. Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2011,11(6):683-692.
APA Yang, Weimin.,Qiang, Dongjin.,Zhang, Min.,Ma, Limei.,Zhang, Yonghui.,...&Chen, Yan-Hua.(2011).Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models.INTERNATIONAL IMMUNOPHARMACOLOGY,11(6),683-692.
MLA Yang, Weimin,et al."Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models".INTERNATIONAL IMMUNOPHARMACOLOGY 11.6(2011):683-692.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
201203200026.pdf(2189KB) 开放获取--请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yang, Weimin]的文章
[Qiang, Dongjin]的文章
[Zhang, Min]的文章
百度学术
百度学术中相似的文章
[Yang, Weimin]的文章
[Qiang, Dongjin]的文章
[Zhang, Min]的文章
必应学术
必应学术中相似的文章
[Yang, Weimin]的文章
[Qiang, Dongjin]的文章
[Zhang, Min]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。